TY  - JOUR 
AU  - Paez-Vega, Aurora
AU  - Cantisan, Sara
AU  - Vaquero, Jose Manuel
AU  - Vidal, Elisa
AU  - Luque-Pineda, Antonio
AU  - Lobo-Acosta, Maria Angeles
AU  - Perez, Ana Belen
AU  - Alonso-Moralejo, Rodrigo
AU  - Iturbe, David
AU  - Monforte, Victor
AU  - Otero González, Isabel
AU  - Pastor, Amparo
AU  - Ussetti, Piedad
AU  - Torre-Cisneros, Julian
PY  - 2019
SN  - 2044-6055
UR  - http://hdl.handle.net/20.500.11940/15916
AB  - INTRODUCTION: Prolonged use of antivirals to prevent the development of cytomegalovirus (CMV) disease in lung transplant patients has been shown to have significant side effects, for which alternatives are being sought to reduce their use. The...
LA  - eng
KW  - Immunity
KW  - Humans
KW  - Treatment Outcome
KW  - Combined Modality Therapy
KW  - Time Factors
KW  - Multicenter Studies as Topic
KW  - Lung Transplantation
KW  - Randomized Controlled Trials as Topic
KW  - Postoperative Complications
KW  - Cytomegalovirus Infections
KW  - Antiviral Agents
KW  - Premedication
KW  - Cytomegalovirus
TI  - Efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis to prevent cytomegalovirus disease in lung transplant recipients (CYTOCOR STUDY): an open-label, randomised, non-inferiority clinical trial
DO  - 10.1136/bmjopen-2019-030648
T2  - BMJ Opem
KW  - CHUAC
KW  - INIBIC
VL  - 9
ER  -